Replimune Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include GlycoMimetics.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | ||
Founding Date | Founding Date 1990 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Rockville, US HQ |
Employees | Employees 61821% increase | Employees 5025% increase |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 31.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $10.8m (FY, 2025) |
Net income | Net income ($164.1m) (FY, 2025) | Net income ($153.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 101.8m |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company